Question 1

Am I eligible for this trial based on my current treatments and health status?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Treating Patients With Melanoma and ALK Alterations With Ensartinib clinical trial (NCT03420508). Contact the study team or your healthcare provider for specific answers.

Question 2

What are the potential side effects of ensartinib?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Treating Patients With Melanoma and ALK Alterations With Ensartinib clinical trial (NCT03420508). Contact the study team or your healthcare provider for specific answers.

Question 3

How does ensartinib compare to my current treatment options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Treating Patients With Melanoma and ALK Alterations With Ensartinib clinical trial (NCT03420508). Contact the study team or your healthcare provider for specific answers.

Question 4

What will the treatment schedule look like, and how often will I need to visit the clinic?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Treating Patients With Melanoma and ALK Alterations With Ensartinib clinical trial (NCT03420508). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if my cancer does not respond to this treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Treating Patients With Melanoma and ALK Alterations With Ensartinib clinical trial (NCT03420508). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any specific tests or procedures I will need to undergo during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Treating Patients With Melanoma and ALK Alterations With Ensartinib clinical trial (NCT03420508). Contact the study team or your healthcare provider for specific answers.

What this study is about